Dr. Christopher James Engelman, MD

Dr. Engelman practices at Spectrum Eye Physicians, a Medical Corporation in Los Gatos, California.

Dr. Engelman's NPI, 1093778326, was assigned on April 8, 2006. Dr. Engelman graduated from Tufts University School Of Medicine in 1998. Dr. Engelman's California license number on file is A69913.

Dr. Engelman's primary practice is Spectrum Eye Physicians, a Medical Corporation, at 431 Monterey Ave, Los Gatos, CA 95030 in Santa Clara County. The practice phone is (408) 253-3083.

Dr. Engelman's primary practice is Spectrum Eye Physicians, a Medical Corporation in Los Gatos, California. Dmand AI also links Dr. Engelman to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Engelman practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Engelman's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Engelman is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Engelman's licenses on file in 2 states: California and Oregon.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation and eyelid inflammation among the conditions Dr. Engelman treats.

CMS data shows 4,375 Medicare services from Dr. Engelman across 18 procedure codes in 2024, for 1,012 Medicare patients. Medicare paid $401,432 for them.

CMS counts 1,012 Medicare patients who saw Dr. Engelman in 2024. The largest group is 75 to 84, with 476 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 4% are also on Medicaid. Their average risk score is 0.96, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Engelman's median patient age at 74, with 58% women.

In 2024, Dr. Engelman wrote 4,243 Medicare Part D claims for 745 patients. 53% of them were for generic drugs. CMS names the drug for 4,157 of them, across 32 drugs with 11 or more claims each, at $633,530 in total drug cost. In 2023, CMS named 4,629 claims across 29 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Engelman for performance year 2024, reported as part of a group. Dr. Engelman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 157 procedures of cataract surgery by Dr. Engelman, more than 80% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Engelman. Dr. Engelman's most frequent co-authors are Mark Blumenkranz, MD and Peter R. Egbert.

Dmand AI links Dr. Engelman to 2 clinical trials. Conditions studied include Glaucoma, Glaucoma, Open-Angle and Ocular Hypertension.

CMS Open Payments shows 240 general payments to Dr. Engelman from 21 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 49% of the total. Aerie Pharmaceuticals, Inc. paid the most, $9,601.

Dmand AI lists 1 award for Dr. Engelman.

Dr. Engelman graduated from Tufts University School Of Medicine in 1998. Dr. Engelman is a member of AAO.

Dr. Engelman is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.